ArticleVaccines2025

Efficacy and Safety of Anti-Respiratory Syncytial Virus Monoclonal Antibody Nirsevimab in Neonates: A Real-World Monocentric Study.

Maria Costantino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.